Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy

NCT04440280 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Fuchs Endothelial Corneal Dystrophy

Interventions

DRUG: N-acetyl cysteine (NAC) 10% solution
DRUG: N-acetyl cysteine (NAC) 20% solution
DRUG: Visine Dry Eye Relief eye drops

Sponsor

Massachusetts Eye and Ear Infirmary